The Impact of Cardiovascular Risk, Baseline LDL-Cholesterol, Treatment Dose and Adherence on Cost-Effectiveness of Statins in Newly Diagnosed Diabetes Patients

被引：0
|
作者：
de Vries, Dianna [1 ]
Hak, Eelko [1 ]
Postma, Maarten J. [1 ]
机构：
[1] Univ Groningen, PharmacoEpidemiol & PharmacoEcon, Groningen, Netherlands
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2015年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
63
引用
收藏
页码：37 / 38
页数：2
相关论文
共 50 条
  • [1] A cost-effectiveness model of alternative statins to achieve target LDL-cholesterol levels
    Maclaine, GDH
    Patel, H
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2001, 55 (04) : 243 - 249
  • [2] Cost-Effectiveness of Statins for Primary Prevention in Patients Newly Diagnosed with Type 2 Diabetes in The Netherlands
    de Vries, Folgerdiena M.
    Denig, Petra
    Visser, Sipke T.
    Hak, Eelko
    Postma, Maarten J.
    VALUE IN HEALTH, 2014, 17 (02) : 223 - 230
  • [3] COST-EFFECTIVENESS OF STATINS FOR PRIMARY PREVENTION IN NEWLY DIAGNOSED TYPE 2 DIABETES PATIENTS IN THE NETHERLANDS
    de Vries, F. M.
    Denig, P.
    Visser, S. T.
    Hak, E.
    Postma, M. J.
    VALUE IN HEALTH, 2013, 16 (07) : A526 - A526
  • [4] The cost-effectiveness of atorvastatin, rosuvastatin and simvastatin in treating patients to LDL-cholesterol targets
    Niskanen, L.
    Peura, P. K.
    Hallinen, T.
    Soini, E.
    Martikainen, J.
    EUROPEAN HEART JOURNAL, 2007, 28 : 860 - 860
  • [5] Modelling the cost-effectiveness of statin therapy for treating patients to target LDL-cholesterol
    Maclaine, GDH
    Patel, H
    EUROPEAN HEART JOURNAL, 2000, 21 : 219 - 219
  • [6] Statin Adherence and Treatment LDL-Cholesterol Response in Type 2 Diabetes Patients
    de Vries, Dianna
    Voorham, Jaco
    Hak, Eelko
    Denig, Petra
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 322 - 323
  • [7] Cost-Effectiveness of Statins for Primary Prevention in Newly Diagnosed Type 2 Diabetes Patients: An Illustration for the Netherlands
    de Vries, Folgerdiena M.
    Denig, Petra
    Visser, Sipke T.
    Hak, Eelko
    Postma, Maarten J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 117 - 118
  • [8] COST-EFFECTIVENESS OF STATINS FOR PRIMARY PREVENTION IN PATIENTS NEWLY DIAGNOSED WITH TYPE 2 DIABETES IN THE CHINESE CONTEXT
    Wu, B.
    Ma, J.
    Xie, X.
    VALUE IN HEALTH, 2018, 21 : S39 - S39
  • [9] The Cost-Effectiveness of "Getting to Goal" in Patients with Newly Diagnosed Type 2 Diabetes
    Willis, Michael
    Asseberg, Christian
    He, Jianming
    Neslusan, Cheryl
    DIABETES, 2009, 58 : A45 - A45
  • [10] Does baseline LDL-cholesterol predict cardiovascular outcomes in high cardiovascular risk hypertensive patients? Insights from an Asian population
    Shi, Wenrui
    Zhou, Yaping
    Chen, Yihan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 297 : 141 - 141
12345